Jason Tardio - Chief Operating Officer at Ovid Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Operating Officer
Stock Symbol
OVID on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jason Tardio since 12/23/2023

Holdings reported by Jason Tardio for Ovid Therapeutics Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 28.1K $60.5K $2.15 Feb 22, 2024 Direct
Stock Option (Right to Buy) 169K Feb 22, 2024 Direct Common Stock

Transactions reported by Jason Tardio for Ovid Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.